‘Ozempic babies': Reports of surprise pregnancies raise new questions about weight loss drugs

Catera Bentley was overjoyed to discover she was pregnant after struggling with infertility due to polycystic ovary syndrome (PCOS). Bentley had been taking Mounjaro for weight loss and had experienced positive changes in her body, including regular menstrual cycles. Concerned about the effects of the drug on her baby, Bentley stopped taking it as soon as she found out she was pregnant. GLP-1 receptor agonists like Mounjaro and Ozempic, used for diabetes and weight loss, have been associated with increased fertility. However, their safety during pregnancy is largely unknown, as pregnant women were excluded from clinical trials. More research is needed to understand the implications of these medications on pregnant women and their babies.